XML 52 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of components and classification of financial assets and liabilities measured at fair value on a recurring basis
The following fair value hierarchy table presents the components and classification of the Company’s financial assets and liabilities measured at fair value on a recurring basis as of:
 December 31, 2023December 31, 2022
 (in millions)TotalLevel 1Level 2Level 3TotalLevel 1Level 2Level 3
Assets:        
Cash equivalents$425 $417 $$— $94 $85 $$— 
Restricted cash and other settlement deposits$15 $15 $— $— $27 $27 $— $— 
Foreign currency exchange contracts$$— $$— $$— $$— 
Liabilities:    
Acquisition-related contingent consideration$292 $— $— $292 $241 $— $— $241 
Cross-currency swaps$84 $— $84 $— $39 $— $39 $— 
Foreign currency exchange contracts$$— $$— $$— $$— 
Schedule of assets and liabilities associated with derivatives, included in the Consolidated Balance Sheets
The assets and liabilities associated with the Company’s cross-currency swaps as included in the Consolidated Balance Sheets as of December 31, 2023 and 2022 are as follows:
(in millions)20232022
Other non-current liabilities$(90)$(45)
Prepaid expenses and other current assets$$
Net fair value$(84)$(39)
The assets and liabilities associated with the Company’s foreign exchange contracts as included in the Consolidated Balance Sheets as of December 31, 2023 and 2022 are as follows:
(in millions)20232022
Accrued and other current liabilities$(6)$(4)
Prepaid expenses and other current assets$$
Net fair value$(3)$
Schedule of effect of hedging instruments on financial statements
The following table presents the effect of hedging instruments on the Consolidated Statements of Operations and Consolidated Statements of Comprehensive Loss for 2023 and 2022:
(in millions)20232022
Loss recognized in Other comprehensive loss$45 $45 
Gain excluded from assessment of hedge effectiveness$13 $
Location of gain of excluded componentInterest Expense
Schedule of foreign exchange contracts on the Consolidated Statements of Operations and Consolidated Statements of Cash Flows
The following table presents the effect of the Company’s foreign exchange contracts on the Consolidated Statements of Operations and the Consolidated Statements of Cash Flows for 2023 and 2022:
(in millions)20232022
(Loss) Gain related to changes in fair value$(5)$
Gain (loss) related to settlements$$(20)
Schedule of reconciliation of contingent consideration obligations measured on a recurring basis using significant unobservable inputs
The following table presents a reconciliation of contingent consideration obligations measured on a recurring basis using significant unobservable inputs (Level 3) for the years 2023 and 2022:
(in millions)20232022
Beginning balance, January 1, $241 $241 
Adjustments to Acquisition-related contingent consideration:
Accretion for the time value of money$19 $16 
Fair value adjustments due to changes in estimates of other future payments40 12 
Acquisition-related contingent consideration59 28 
Additions (Note 3)38 — 
Payments / Settlements(46)(28)
Ending balance, December 31,292 241 
Current portion39 34 
Non-current portion$253 $207